Vijay Shreedhar, Chief Commercial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 1,051 shares at $5.50 ($6K) on 2021-03-22, disclosed to the SEC on 2021-03-23.
Open-market sale of $6k ADMS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |